Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Shen-Duo Li · SciRah

Researcher profile · Semantic Scholar

Shen-Duo Li

Share profile

Shen-Duo Li — researcher profile on SciRah

h-index: 12
Works: 50
Citations: 451

Most-cited papers

Model of Tumor Dormancy/Recurrence after Short-Term Chemotherapy
Shen-Duo Li, M. Kennedy, Sturgis Payne, Kelly M. Kennedy +3 more
2014PLoS ONE86 citations Open access
Semantic Scholar
RefAI: a GPT-powered retrieval-augmented generative tool for biomedical literature recommendation and summarization
Yi-Ming Li, Jeff Zhao, Man-Qi Li, Y. Dang +19 more
2024J. Am. Medical Informatics Assoc.59 citations Open access
Semantic Scholar
Emerging Targeted Therapies in Advanced Non-Small-Cell Lung Cancer
Shen-Duo Li, G. S. de Camargo Correia, Jing Wang, R. Manochakian +2 more
2023Cancers54 citations Open access
Semantic Scholar
Efficacy and clinicogenomic correlates of response to immune checkpoint inhibitors alone or with chemotherapy in non-small cell lung cancer
L. Hong, M. Aminu, Shen-Duo Li, Xuetao Lu +33 more
2023Nature Communications42 citations Open access
Semantic Scholar
Nuclear basic fibroblast growth factor regulates triple-negative breast cancer chemo-resistance
Shen-Duo Li, Sturgis Payne, Fang Wang, P. Claus +8 more
2015Breast Cancer Research34 citations Open access
Semantic Scholar
Circulating DNA in EGFR-mutated lung cancer.
Aditi P. Singh, Shen-Duo Li, Hai-Ying Cheng
2017Annals of Translational Medicine26 citations Open access
Semantic Scholar
Chemotherapy enriches for an invasive triple-negative breast tumor cell subpopulation expressing a precursor form of N-cadherin on the cell surface
Erik R. Nelson, Shen-Duo Li, M. Kennedy, Sturgis Payne +12 more
2016OncoTarget19 citations Open access
Semantic Scholar
Heterogeneous Expression of PD-L1, B7x, B7-H3, and HHLA2 in Pulmonary Sarcomatoid Carcinoma and the Related Regulatory Signaling Pathways
Feng Wang, A. E. Cali Daylan, L. Deng, Ji-Hua Yang +7 more
2023Cancers17 citations Open access
Semantic Scholar
Targeting Lung Cancer with Precision: The ADC Therapeutic Revolution
R. Tawfiq, G. S. de Camargo Correia, Shen-Duo Li, Yu-Jie Zhao +2 more
2025Current Oncology Reports16 citations
Semantic Scholar
Emerging Immunotherapies for Advanced Non-Small-Cell Lung Cancer
Emily B. Wolf, Guilherme Sacchi de Camargo Correia, Shen-Duo Li, Yu-Jie Zhao +2 more
2025Vaccines15 citations Open access
Semantic Scholar
Aurora Kinase A Inhibition Potentiates Platinum and Radiation Cytotoxicity in Non-Small-Cell Lung Cancer Cells and Induces Expression of Alternative Immune Checkpoints
Hui-Jie Liu, A. E. Cali Daylan, Jihua Yang, A. Tanwar +8 more
2024Cancers14 citations Open access
Semantic Scholar
Detection of plasma EGFR mutations for personalized treatment of lung cancer patients without pathologic diagnosis
Qin-Fang Deng, Qiyu Fang, Hui Sun, Aditi P. Singh +4 more
2020Cancer Medicine12 citations Open access
Semantic Scholar
Machine-learning driven strategies for adapting immunotherapy in metastatic NSCLC
Maliazurina B. Saad, Qasem Al-Tashi, L. Hong, V. Verma +33 more
2025Nature Communications11 citations Open access
Semantic Scholar
Immune-Related Adverse Events in Patients with Lung Cancer
Guilherme Sacchi de Camargo Correia, T. Pai, Shen-Duo Li, Dana Connor +3 more
2023Current Oncology Reports9 citations
Semantic Scholar
Expression, correlation, and prognostic significance of different nicotinic acetylcholine receptors, programed death ligand 1, and dopamine receptor D2 in lung adenocarcinoma
Krishnendu Pal, Tabish Hussain, Hao Xie, Shen-Duo Li +5 more
2022Frontiers in Oncology7 citations Open access
Semantic Scholar
Early discontinuation of immune checkpoint inhibitor therapy prior to disease progression in patients with metastatic non-small cell lung cancer: a survival analysis
B. McKinley, T. Pai, Emily B. Wolf, Shen-Duo Li +4 more
2024Frontiers in Oncology6 citations Open access
Semantic Scholar
First Report of Management of Sequential Small Cell Transformation and ALK I1171T Mutation as Resistance Mechanisms in a Patient With ALK-EML4 Fused Non–Small Cell Lung Adenocarcinoma With a Novel Combination of Temozolomide and Lorlatinib: A Case Report
U. Majeed, Shen-Duo Li, K. Seegobin, A. Nassar +3 more
2023JTO Clinical and Research Reports5 citations Open access
Semantic Scholar
Lung Cancer in Patients With Lynch Syndrome: Association or Coincidence?
U. Majeed, K. Seegobin, J. Lewis, Shen-Duo Li +3 more
2023Clinical Lung Cancer4 citations
Semantic Scholar
Clinical Benefit from Docetaxel +/− Ramucirumab Is Not Associated with Mutation Status in Metastatic Non-Small-Cell Lung Cancer Patients Who Progressed on Platinum Doublets and Immunotherapy
Kang Qin, Kai-Wen Wang, Shen-Duo Li, L. Hong +16 more
2024Cancers3 citations Open access
Semantic Scholar
P2.01-056 Distinct PD-L1 Expression in Different Components of Pulmonary Sarcomatoid Carcinoma and Its Association with MET Mutation: Topic: Immune Mechanisms in Thoracic Cancer and Targeted Therapy
Janaki Sharma, A. Borczuk, Hui-Jie Liu, Shen-Duo Li +3 more
20173 citations Open access
Semantic Scholar
Immunotherapy and Radiation for Clinical Perineural Invasion in Cutaneous Squamous Cell Carcinoma
Renée Morecroft, Jordan Phillipps, Lang Gou, A. Bhatt +18 more
2025Cancers2 citations
Semantic Scholar
Clinical outcomes of atezolizumab versus standard-of-care docetaxel with and without ramucirumab in patients with advanced non-small-cell lung cancer who received prior immunotherapy
Shen-Duo Li, R. Manochakian, Ru-Qin Chen, Jaydeepbhai Patel +4 more
2024Frontiers in Oncology2 citations Open access
Semantic Scholar
Incidence of additional primary malignancies in patients with malignant peritoneal mesothelioma.
Vivek Pandav, Jaydeepbhai Patel, J. Inampudi, Shen-Duo Li +6 more
2023Journal of Clinical Oncology2 citations Open access
Semantic Scholar
Emerging Immunotherapy and Antibody-Derived Therapeutics for the Treatment of Advanced Non-Small-Cell Lung Cancer: A Review
Alicia Y. Hou, D. Elantably, R. Manochakian, V. Velcheti +3 more
2026Cancers1 citations
Semantic Scholar
Immune checkpoint inhibitors (ICI) in thymic epithelial tumors (TET): A real world assessment of efficacy and toxicity.
Guilherme Sacchi de Camargo Correia, R. Tawfiq, Yanyan Lou, Yu-Jie Zhao +4 more
2025Journal of Clinical Oncology1 citations Open access
Semantic Scholar
Osimertinib and Cardiotoxicity: A Topic to Keep Addressing.
Shen-Duo Li, R. Manochakian, Yu-Jie Zhao, Yanyan Lou
2025Journal of Thoracic Oncology1 citations
Semantic Scholar
Novel Assessment of Advanced Practice Provider‐Led Head and Neck Cancer Survivorship Clinic: Quality‐of‐Care Metric Analysis and HOUSES Index Application
K. Wert, B. May, J. Janus, Samip Patel +11 more
2025Head and Neck1 citations
Semantic Scholar
Disease monitoring using plasma-based circulating tumor DNA (ctDNA) assays in rare malignancies.
Shen-Duo Li, Dana Connor, Lyndsey L Fournier, Sarika Rao +3 more
2024Journal of Clinical Oncology1 citations Open access
Semantic Scholar
Estimating the Average Treatment Effect Using Weighting Methods in Lung Cancer Immunotherapy
Maliazurina B. Saad, Qasem Al-Tashi, L. Hong, Wen-Tao Li +6 more
2024CMMCA@MICCAI1 citations
Semantic Scholar
Abstract 4003: Path-IO: A deep learning pathomics framework for personalized immunotherapy selection and outcome prediction in metastatic non-small cell lung cancer
Rukhmini Bandyopadhyay, Ling Hong, M. Aldea, Shen-Duo Li +39 more
2026Cancer Research0 citations
Semantic Scholar
Immune Checkpoint Inhibitors in Unresectable or Metastatic Thymic Epithelial Tumors--A Real-World Assessment of Efficacy and Toxicity.
Guilherme Sacchi de Camargo Correia, R. Tawfiq, Ru-Qin Chen, Yanyan Lou +6 more
2026Clinical Lung Cancer0 citations Open access
Semantic Scholar
LLM-assisted identification of baseline predictors of cardiovascular immune-related adverse events in ICI-treated lung cancer: A retrospective real world study.
K. Gupta, A. Abdelhameed, H. Mahadevia, Y. Arya +8 more
2026JCO Oncology Practice0 citations Open access
Semantic Scholar
Deep learning of CT imaging predicts PD-L1 expression and immunotherapy response in metastatic NSCLC: A multi-center study
A. Muneer, E. Showkatian, Maliazurina B. Saad, L. Hong +27 more
2026Cancer Letters0 citations Open access
Semantic Scholar
Differentiation and stage as independent predictors of survival in laryngeal neuroendocrine carcinoma: A SEER analysis.
Ines Visa, Shen-Duo Li, Yanyan Lou, Yu-Jie Zhao
2026Journal of Clinical Oncology0 citations
Semantic Scholar
Assessing the true burden of immune-related colitis in lung cancer through large language model–enabled clinical phenotyping.
H. Mahadevia, A. Abdelhameed, Alicia Y. Hou, D. Elantably +9 more
2026Journal of Clinical Oncology0 citations
Semantic Scholar
The role of Quad Shot in palliative radiotherapy: narrative review of the evidence and applications in advanced head and neck cancer.
David J. Crompton, Homan Mohammadi, M. Wear, K. Wert +11 more
2026Annals of Palliative Medicine0 citations Open access
Semantic Scholar
Assessment of survival and role of chemotherapy in patients with adrenocortical carcinoma: Insights from SEER Database (2000–2021).
J. Kuhlman, Sarika Rao, Guilherme Sacchi de Camargo Correia, Emily Wolf +5 more
2025Journal of Clinical Oncology0 citations Open access
Semantic Scholar
Curative immunotherapy-based strategies for non-metastatic non-small cell lung cancer
J. Kuhlman, Shen-Duo Li, R. Manochakian, Y. Lou +1 more
2024Exploration of Targeted Anti-tumor Therapy0 citations Open access
Semantic Scholar
1236 Machine learning-based clinico-genomic prediction of benefits to add chemotherapy to immunotherapy in metastatic non-small cell lung cancer
Maliazurina B. Saad, Qasem Al-Tashi, L. Hong, Wen-Tao Li +23 more
2024Regular and Young Investigator Award Abstracts0 citations Open access
Semantic Scholar
Real-world outcomes comparison between the MET inhibitors (METi) capmatinib and tepotinib in patients with stage IV non-small cell lung cancer (NSCLC) with MET exon 14 skipping mutation.
Guilherme Sacchi de Camargo Correia, Yanyan Lou, Yu-Jie Zhao, Shen-Duo Li +6 more
2024Journal of Clinical Oncology0 citations Open access
Semantic Scholar
Retrospective analysis of the multikinase inhibitor (MKI) pazopanib in differentiated thyroid carcinoma (DTC) in the beyond-first-line setting.
J. Inampudi, H. Mahadevia, Alexandra Stone, A. Toby +9 more
2023Journal of Clinical Oncology0 citations
Semantic Scholar
Assessing the frequency of anemia evaluations in patients who are transfusion-dependent in an academic hematology and oncology practice.
Shen-Duo Li, Blake J. McKinley, O. Mosalem, Joseph Kim +2 more
2023Journal of Clinical Oncology0 citations Open access
Semantic Scholar
Effect of immunotherapy cessation without disease progression on outcomes in patients with metastatic non-small cell lung cancer.
Blake J. McKinley, Shen-Duo Li, N. Wiest, E. Butts +10 more
2023Journal of Clinical Oncology0 citations Open access
Semantic Scholar
Comparison of atezolizumab monotherapy to docetaxel with and without ramucirumab in patients with advanced non-small-cell lung cancer who received prior immunotherapy.
Shen-Duo Li, J. Inampudi, Koshiya R. Hiren, Jaydeepbhai Patel +3 more
2023Journal of Clinical Oncology0 citations
Semantic Scholar
When not having a tissue may not be an issue in advanced lung cancer.
Shen-Duo Li, Y. Lou, R. Manochakian
2023Chinese Clinical Oncology0 citations Open access
Semantic Scholar
Uptake of palliative care services in patients with non-small cell lung cancer receiving immune checkpoint inhibitor therapy: The Mayo Clinic Florida experience.
T. Pai, Shen-Duo Li, Guilherme Sacchi de Camargo Correia, O. Mosalem +6 more
2023JCO Oncology Practice0 citations
Semantic Scholar
Association of docetaxel efficacy with cancer gene mutation status in patients with metastatic non-small-cell lung cancer who progressed on platinum doublets and immunotherapy.
K. Qin, Kai-Wen Wang, Shen-Duo Li, L. Hong +10 more
2023Journal of Clinical Oncology0 citations
Semantic Scholar
Mutational profile, clinical characterization, and outcomes of lung cancer in solid organ transplant recipients.
Shen-Duo Li, R. Manochakian, Yujie Zhao, Y. Lou
2022Journal of Clinical Oncology0 citations
Semantic Scholar
Circulating free DNA (cfDNA) for personalized treatment of lung cancer patients without cytopathologic diagnosis.
Aditi P. Singh, Qin-Fang Deng, Qiyu Fang, Hui Sun +3 more
20180 citations
Semantic Scholar
Nuclear Basic Fibroblast Growth Factor Regulation of Triple-Negative Breast Cancer Dormancy/Recurrence
Shen-Duo Li
20140 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

R. Manochakian×25
Invite
R. Manochakian — researcher profile on SciRah
Y. Lou×19
Invite
Y. Lou — researcher profile on SciRah
Yu-Jie Zhao×17
Invite
Yu-Jie Zhao — researcher profile on SciRah
Yanyan Lou×8
Invite
Yanyan Lou — researcher profile on SciRah

×8

Invite

Yujie Zhao — researcher profile on SciRah

Invite

N. Vokes — researcher profile on SciRah

Guilherme Sacchi de Camargo Correia×8

Invite

Guilherme Sacchi de Camargo Correia — researcher profile on SciRah

Invite

Yanyan Lou — researcher profile on SciRah

Invite

L. Hong — researcher profile on SciRah

Maliazurina B. Saad×6

Invite

Maliazurina B. Saad — researcher profile on SciRah

A. Vaporciyan×6

Invite

A. Vaporciyan — researcher profile on SciRah

Invite

T. Cascone — researcher profile on SciRah